The Almagest | GO drug may improve outcome of bone marrow transplantation for select ... News-Medical.net Combining the drug gemtuzumab ozogamicin (GO) with conventional chemotherapy may improve the outcome of bone marrow transplantation for some children battling high-risk acute myeloid leukemia (AML), according to a study led by St. Jude Children's ... St. Jude: Drug/chemo combo offers new hope for children with high-risk leukemia |
